Mirion Technologies (MIR) Q2 FY26 earnings call: guidance and Q&A

How much of the large opportunity pipeline is likely to convert to Mirion, and what are the primary risks?

Management believes they have a 'right to win' on all opportunities in the pipeline, which are screened for >$10M scope and >50% win probability. They won all opportunities that transacted last quarter. The biggest risk is timing, as projects can be delayed, but the opportunity set is replenishing.

“I think if we look at the opportunities that actually traded in the last quarter, I believe we won all of them. I don't think we lost anything that actually transacted over that period of time. And so we remain optimistic about our ability to continue that track record. In our view, the -- in general, the biggest risk is timing risk, where, depending on the nature of the project, the sector that it's in, et cetera, they can have a tendency to move to the right.”

asked by James West · answered by Thomas Logan

Has the M&A pipeline changed, and should we expect announcements?

The M&A pipeline remains strong with many interesting, complementary assets. M&A is a core part of their strategy, with roughly 20 deals in the last decade, and they expect to remain active.

“I would characterize our M&A pipeline as one of continued strength. There are a lot of really interesting assets in the market that we view as being highly complementary strategically to our business model. And this -- M&A, to be clear, has always been an important part of our strategy. We've done roughly 20 deals over the last decade. And our expectation is that we're going to continue to be active in this realm.”

asked by James West · answered by Thomas Logan

How much of the implied mid-teens organic growth for Nuclear & Safety in Q4 is already in backlog, and what drives this ramp?

The 81% full-year revenue coverage (from H1 actuals and backlog) is comparable to prior years. While Q4's implied growth is significant, the comps for the back half of the year are easier. The step-up is expected across SMR, new build, and the operating fleet (MPP, 80% of nuclear power revenue).

“I think your math is right. I think we put the visibility out there kind of for the rest of the year, we put it in totality. So 81%. So we're sitting kind of exactly where we sat at this point in every other quarter coming out of Q2. And a reminder, when we look backwards, we're talking about where we actually landed from a revenue perspective over what we thought would trade from a backlog perspective. So it's a pretty apples-to-apples comparison.”

asked by Joseph Ritchie · answered by Brian Schopfer

Given the $18M China debooking, what is the potential risk from other legacy contracts in the backlog, and why was this specific contract debooked now?

Debooking events are rare and tied to broader issues (e.g., Ukraine conflict, localized disputes). This $18M contract was stalled due to geopolitical tensions since 2019. Management continuously scrutinizes backlog and sees no elevated risk or broader trigger event. Mirion has a strong position in 50/60 Chinese reactors, with a robust spare parts market ($8M/year) and ongoing export opportunities for non-indigenous reactor types.

“But having said all of that, this was a contract that essentially was undergirded by a project that was making very little progress. It is a contract that was booked many years ago and has candidly been impacted by some of the changed trading dynamics specifically between the U.S. and China. So looking beyond that, when we look at our backlog quality, our view is it continues to be very high. We don't see any level of elevated risk.”

asked by Joseph Ritchie · answered by Thomas Logan

Based on current order momentum, should SMR revenue scale further beyond 2027?

Management is increasingly bullish on the SMR sector, noting that the timeline for commercial deployment is accelerating. They see a stronger opportunity flow and unique positioning. They expect SMR growth to continue at a rate faster than overall organic growth for the rational planning horizon.

“What I would say, Quinn, is that the continuing theme here is that while historically, we have been very cautious about expressing confidence in the SMR timeline overall, the reality continues to move to the left. We are seeing a stronger and stronger opportunity flow in this sector. Our positioning here is somewhat unique when you look at the breadth of our capabilities that are relevant to these players overall.”

asked by Quinn Fredrickson · answered by Thomas Logan

Why has the disconnect between strong nuclear power order growth (47% ex-M&A) and flat revenue persisted, and what drives the Q3 ramp?

To hit back-end numbers, a step-up is expected across all three nuclear power business pieces: SMR, new build, and operating fleet (MPP). The nuclear power growth in Q2 was half from the installed base and half from SMRs. The 81% revenue coverage for the full year is consistent with prior years, and H2 benefits from easier comparables.

“So I mean, look, in order to hit the back end numbers, I mean, I think we're expecting a step-up kind of in all 3 pieces of the nuclear power business; SMR, new build and MPP. And just as a reminder, I mean MPP is 80% of our nuclear power revenue. Obviously to hit the back end of the numbers, we need to see that business work.”

asked by Andy Kaplowitz · answered by Brian Schopfer

Is the 30% EBITDA target for FY28 still achievable given current margins, and what are the key drivers for margin expansion?

The 30% target is audacious but achievable. Key drivers include operating leverage (half or more of the gain), procurement efficiency (1-2 points from in-stream opportunities), and self-help initiatives (business system application, AI for productivity, conversion efficiency, factory footprint optimization, administrative workflows). A recent organizational restructuring reserve will also provide a near-term benefit.

“So Chris, just to begin at a high level and talk about the major building blocks that walk us up that essentially that 4.5 points of go get, if you take the midpoint of the guide on year-end '26 EBITDA margins in that 25.5 point range overall. As we've talked about extensively in the past, the biggest building block for us is operating leverage.”

asked by Christopher Moore · answered by Thomas Logan

With stronger free cash flow and lower leverage targets, how is Mirion thinking about medium-term capital allocation, including AI investment and M&A?

Without M&A, the company expects to end the year at approximately 2.5x leverage. M&A remains the first strategic priority for capital allocation, with a decent pipeline of smaller-sized deals. AI investment is currently running at about $5 million annually, mostly OpEx, and is a growing, material number that is considered in margin dynamics.

“Yes. Tomo, if we did no M&A for the balance of the year looking at our operating plans and our capital spending plans, we'd end the year at about 2.5x leverage, somewhere in that range. Again, we've got a decent pipeline within that. These tend to be smaller-sized deals. So our first priority strategically as we think about capital allocation generally is M&A, but there will invariably be a net reduction in leverage over the course of the year and the degree to which that's impacted by M&A is TBD.”

asked by Tomohiko Sano · answered by Thomas Logan